Journal of Korean Academy of Nursing (대한간호학회지)

Korean Society of Nursing Science (한국간호과학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer

유방암 환자에서 화학요법관련 인지기능저하의 발생률과 발생양상

  • Received : 2014.09.12
  • Accepted : 2015.01.13
  • Published : 2015.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Evidence suggests that some patients with breast cancer experience cognitive difficulties following chemotherapy. This longitudinal study was done to examine the prevalence of cognitive impairment and trajectory of cognitive function over time in women with breast cancer, who received adjuvant chemotherapy. Methods: Participants were 137 patients with breast cancer. They completed neuropsychological tests and the Functional Assessment of Cancer Therapy-Cognitive Function before adjuvant therapy (pretest), toward the end of adjuvant therapy (posttest), and 6 months after the completion of adjuvant therapy (follow-up test). Of the patients, 91 were treated with adjuvant chemotherapy and 46 patients who did not receive chemotherapy made up the comparison group. A reliable-change index and repeated-measure ANOVA were used for statistical analyses. Results: At the posttest point, over 30% of patients showed complex cognitive impairment and reported greater difficulty in subjective cognitive function. At the follow-up test point, 22.0% of patients exhibited complex cognitive impairment and 30.8% of patients complained of subjective cognitive impairment. Repeated-measure ANOVA showed significant decreases after receiving chemotherapy followed by small improvements 6 months after the completion of chemotherapy in cognitive domains of change for attention and concentration, memory, executive function, and subjective cognitive function. Conclusion: These results suggest that chemotherapy in patients with breast cancer may be associated with objective and subjective cognitive impairments. Further studies are needed to explore the potential risk factors and predictor of chemotherapy-related cognitive changes. Also nursing interventions for prevention and intervention of cognitive impairments should be developed and tested.

Keywords

References

  1. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2011. Cancer Research and Treatment. 2014;46(2):109-123. http://dx.doi.org/10.4143/crt.2014.46.2.109
  2. Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study. Journal of Clinical Nursing. 2010;19(9-10):1362-1370. http://dx.doi.org/10.1111/j.1365-2702.2009.03006.x
  3. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005;12(4):279-287. https://doi.org/10.2325/jbcs.12.279
  4. Park JH, Bae SH. A meta-analysis of chemotherapy related cognitive impairment in patients with breast cancer. Journal of Korean Academy of Nursing. 2012;42(5):644-658. http://dx.doi.org/10.4040/jkan.2012.42.5.644
  5. Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer. 2002;3(Suppl 3):S84-S90. https://doi.org/10.3816/CBC.2002.s.018
  6. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews. 2012;38(7):926-934. http://dx.doi.org/10.1016/j.ctrv.2012.05.002
  7. Myers JS. Chemotherapy-related cognitive impairment: The breast cancer experience. Oncology Nursing Forum. 2012;39(1):E31-E40. http://dx.doi.org/10.1188/12.onf.e31-e40
  8. Collins B, Mackenzie J, Kyeremanteng C. Study of the cognitive effects of chemotherapy: Considerations in selection of a control group. Journal of Clinical and Experimental Neuropsychology. 2013;35(4):435-444. http://dx.doi.org/10.1080/13803395.2013.781995
  9. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer. 2011;19(10):1647-1656. http://dx.doi.org/10.1007/s00520-010-0997-4
  10. Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: A controlled comparison. Cancer. 2009;115(8):1776-1783. http://dx.doi.org/10.1002/cncr.24192
  11. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer. 2007;109(9):1905-1913. http://dx.doi.org/10.1002/cncr.22610
  12. Ouimet LA, Stewart A, Collins B, Schindler D, Bielajew C. Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology. 2009;31(1):73-89. http://dx.doi.org/10.1080/13803390801992725
  13. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after chemotherapy in breast cancer patients. Journal of the International Neuropsychological Society. 2009;15(6):951-962. http://dx.doi.org/10.1017/s1355617709990567
  14. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292-2299. http://dx.doi.org/10.1002/cncr.20272
  15. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry. 2014;26(1):102-113. http://dx.doi.org/10.3109/09540261.2013.864260
  16. Avisar A, River Y, Schiff E, Bar-Sela G, Steiner M, Ben-Arye E. Chemotherapy-related cognitive impairment: Does integrating complementary medicine have something to add? Review of the literature. Breast Cancer Research and Treatment. 2012;136(1):1-7. http://dx.doi.org/10.1007/s10549-012-2211-5
  17. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA. Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of Clinical Oncology. 2007;25(25):3866-3870. http://dx.doi.org/10.1200/jco.2007.10.8639
  18. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist. 2006;20(1):76-89. http://dx.doi.org/10.1080/138540491005875
  19. Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum. 2007;34(5):997-1005. http://dx.doi.org/10.1188/07.onf.997-1005
  20. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, et al. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast Cancer Research and Treatment. 2010;123(1):25-34. http://dx.doi.org/10.1007/s10549-009-0606-8
  21. Wagner LI, Sweet J, Butt Z, Lai JS, Cella D. Measuring patient self-reported cognitive function: Development of the functional assessment of cancer therapy-cognitive function instrument. The Journal of Supportive Oncology. 2009;7(6):W32-W39.
  22. Chelune GJ, Naugle RI, Luders H, Sedlak J, Awad IA. Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology. 1993;7(1):41-52. http://dx.doi.org/10.1037/0894-4105.7.1.41
  23. Lezak MD, Howieson DB, Loring DW, Hannay J, Fischer JS. Neuropsychological assessment. 4th ed. New York, NY: Oxford University Press;2004.
  24. Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. European Journal of Oncology Nursing. 2013;17(2):236-241. http://dx.doi.org/10.1016/j.ejon.2012.06.002
  25. Cheung YT, Tan EH, Chan A. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Supportive Care in Cancer. 2012;20(7):1361-1375. http://dx.doi.org/10.1007/s00520-012-1445-4
  26. Moon S, Kim SH, Kim MJ. Perceived cognitive function and related factors in Korean women with breast cancer. Asian Nursing Research. 2011;5(2):141-150. http://dx.doi.org/10.1016/s1976-1317(11)60022-4
  27. Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33-50. http://dx.doi.org/10.1016/j.cortex.2014.01.010
  28. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology. 2009;18(2):134-143. http://dx.doi.org/10.1002/pon.1379
  29. Myers JS, Teel C. Oncology nurses' awareness of cognitive impairment secondary to chemotherapy. Clinical Journal of Oncology Nursing. 2008;12(5):725-729. http://dx.doi.org/10.1188/08.cjon.725-729
  30. Chung BY, Cho EJ. Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncology Nursing. 2012;12(3):221-229. http://dx.doi.org/10.5388/aon.2012.12.3.221

Cited by

  1. Changes of Symptom Distress and Quality of Life in Breast Cancer Patients Receiving Adjuvant Therapy vol.15, pp.2, 2015, https://doi.org/10.5388/aon.2015.15.2.67
  2. 대장암 환자의 항암화학요법 관련 인지손상과 삶의 질: 심리적 디스트레스(우울·불안)의 매개효과 vol.46, pp.1, 2015, https://doi.org/10.4040/jkan.2016.46.1.19
  3. 암증상과 피로가 소화기 암 환자의 항암화학요법 관련 인지기능 감퇴와 우울에 미치는 영향 vol.46, pp.3, 2015, https://doi.org/10.4040/jkan.2016.46.3.420
  4. 암 관련 인지 장애의 한의학적 치료에 대한 문헌 고찰 vol.37, pp.3, 2015, https://doi.org/10.13048/jkm.16036
  5. 암 환자를 위한 앱 기반의 인지건강훈련 프로그램의 개발 vol.29, pp.3, 2015, https://doi.org/10.7475/kjan.2017.29.3.266
  6. Mulheres Submetidas à Quimioterapia e suas Funções Cognitivas vol.37, pp.4, 2017, https://doi.org/10.1590/1982-3703004772016
  7. Computerized programs for cancer survivors with cognitive problems: a systematic review vol.13, pp.6, 2015, https://doi.org/10.1007/s11764-019-00807-4
  8. Study on Neurologic and Cognitive Dysfunction in Breast Cancer Patients Undergoing Chemotherapy with Resting State fMRI vol.149, pp.None, 2021, https://doi.org/10.1016/j.wneu.2020.10.088
  9. Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review vol.17, pp.4, 2021, https://doi.org/10.1111/ajco.13484